C
Coherus Oncology, Inc. (CHRS)
NGM – Real vaqt narxi. Valyuta: USD
1.50
+0.02 (1.35%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
1.50
0.00 (0.00%)
Bozordan keyin: Jun 26, 2026, 4:31 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NGM – Real vaqt narxi. Valyuta: USD
1.50
+0.02 (1.35%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
1.50
0.00 (0.00%)
Bozordan keyin: Jun 26, 2026, 4:31 PM EDT
No Data
Ushbu aksiya uchun yangiliklar yo'q.
Kompaniyaning naqd pul zahiralari $115.2M umumiy qarzdan $54.4M sezilarli darajada ko'p bo'lib, kuchli moliyaviy moslashuvchanlikni ta'minlaydi
Jami joriy aktivlar $206.0M jami joriy majburiyatlardan $132.3M ko'p bo'lib, ajoyib likvidlikni ta'kidlaydi
Qarz/kapital nisbati (0.7) tarmoq o'rtachasidan (0.3) sezilarli past bo'lib, ehtiyotkor moliyaviy boshqaruvni namoyish etadi
Foiz qoplash koeffitsiyenti (-16.5x) xavfli darajada past bo'lib, qarzni qaytarish xavflarini ko'rsatadi
Salbiy erkin pul oqimi -$57.9M kompaniyaning qayta investitsiya qilish yoki qarzni to'lash qobiliyatini cheklaydi
| KO‘RSATKICH NOMI | KO‘RSATKICH | SANOAT O‘RTACHASI | 5 YILLIK TREND | BALL |
|---|---|---|---|---|
| Joriy likvidlik ko'rsatkichi | 1.56 | 6.05 | 8.0 | |
| Tezkor likvidlik nisbati | 1.52 | 5.63 | 8.0 | |
| Qarz/Kapital nisbati | 0.69 | 0.30 | 7.0 | |
| Qarz/Aktivlar nisbati | 0.20 | 1.04 | 8.0 | |
| Foiz to‘lov qoplami | -16.54 | -16.91 | 1.0 | |
| O‘rtacha ball | 6.4 | |||
| KO‘RSATKICH | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Jami daromad | 211M | 257M | 26M | 42M | 47M |
| Yalpi foyda | 137M | 94M | 12M | 24M | 28M |
| Operatsion daromad | -257M | -193M | -193M | -180M | -170M |
| Sof foyda | -292M | -238M | -148M | -170M | -152M |
| EBITDA | -253M | -189M | -188M | -176M | -166M |
| Nomi | DAROMAD O'SISHI | EPS O‘SISHI | BALL |
|---|---|---|---|
| Joriy chorak | 92.47 | 37.18 | 10 |
| Keyingi chorak | 44.31 | 25.81 | 10 |
| Joriy yil | 72.71 | 34.94 | 10 |
| Keyingi yil | 21.08 | 37.14 | 10 |
| O‘rtacha ball | 10 | ||
| NOMI | DAROMAD | SOF FOYDA | EPS | FCF | BALL |
|---|---|---|---|---|---|
| Chorak/Chorak | -3.43 | -1.76 | 30.77 | -193.59 | 3.3 |
| Yil/Yil | 61.99 | 32.93 | 34.15 | -124.13 | 7.8 |
| 3 yil o‘rtacha | -2.67 | 13.74 | -193.79 | -153.78 | 2.8 |
| 5 yil o‘rtacha | -14.94 | -55.49 | -183.04 | -223.13 | 1.0 |
| O‘rtacha ball | 3.7 | ||||
Insufficient positive free cash flow for DCF analysis
| NOMI | JORIY | SANOAT | BALL |
|---|---|---|---|
| Dividend foizi | 0.00 | N/A | 1.0 |
| To'lov koeffitsienti | 0.00 | N/A | 1.0 |
| 5 yillik dividend o‘sishi | N/A | N/A | 1.0 |
| Dividend oshgan yillar | N/A | N/A | 1.0 |
| O‘rtacha ball | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NOMI | MASSHTAB | BALL |
|---|---|---|
| Bozor ulushi | Yo'q | 1.0 |
| Nomoddiy aktivlar | Yo'q | 1.0 |
| O'zgartirish xarajatlari | Yo'q | 1.0 |
| Tarmoq ta'siri | Yo'q | 1.0 |
| Masshtab ta'siri | Yo'q | 1.0 |
| O‘rtacha ball | 1.0 | |